A simple procedure for solid-phase synthesis of peptide nucleic acids with N-terminal cysteine

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 16, 1998, Pages 2231-2234

  Goodwin, Thomas E ^a,b   Holland, Ricky D ^c   Lay Jr , Jackson O ^c   Raney, Kevin D ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b HENDRIX COLLEGE   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE NUCLEIC ACID;

ARTICLE; CONFORMATIONAL TRANSITION; NUCLEIC ACID SYNTHESIS; NUCLEOTIDE SEQUENCE; STRUCTURE ANALYSIS;

BASE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; INDICATORS AND REAGENTS; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDE NUCLEIC ACIDS; RESINS, PLANT; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0032544155     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00400-4     Document Type: Article

References (15)

1. 1. (a) Nielsen, P. E.; Egholm, M.; Berg, R. H.; Buchardt, O. Science 1991, 254, 1497;
2. (b) Dueholm, K. L.; Nielsen, P. E. New J. Chem. 1997, 21, 19;
3. (c) Hyrup, B.; Nielsen, P. E. Bioorg. Med. Chem. 1996, 4, 5.
4. 2. For previous synthetic approaches to PNAs and conjugates thereof, see the following and references contained therein: (a) Koch, T.; Hansen, H. F.; Andersen, P.; Larsen, T.; Batz, H. G.; Otteson, K.; Orum, H. J. Peptide Res. 1997, 49, 80;
5. (b) Vinayak, R.; van der Laan, A. C.; Brill, R.; Otteson, K.; Andrus, A.; Kuyl-Yeheskiely, E.; van Boom, J. H. Nucleosides Nucleotides 1997, 16, 1653;
6. (c) van der Laan, A. C.; Brill, R.; Kuimelis, R. G.; Kuyl-Yeheskiely, E.; van Boom, J. H.; Andrus, A.; Vinayak, R. Tetrahedron Lett. 1997, 38, 2249.
7. 3. (a) Simmons, C. G.; Pitts, A. E.; Mayfield, L. D.; Shay, J. W.; Corey, D. R. Bioorg. Med. Chem. Lett. 1997, 7, 3001;
8. (b) Scarfi, S.; Gasparini, A.; Damonte, G.; Benatti, U. Biochem. Biophys. Res. Commun. 1997, 235, 323.
9. 4. For a report on the inhibition of human telomerase activity by PNA, see: Norton, J. C.; Piatyszek, M. A.; Wright, W. E.; Shay, J. W.; Corey, D. R. Nat. Biotech. 1996, 14, 615.
10. 5. Norton, J. C.; Waggenspack, J. H.; Varnum, E.; Corey, D. R. Bioorg. Med. Chem. 1995, 3, 437.
11. 6. Fred Pratt, Perseptive Biosystems, personal communication.
12. 7. Butler, J. M.; Jiang-Baucom, P.; Huang, M.; Belgrader, P.; Girard, J. Anal. Chem. 1996, 68, 3283.
13. 8. Andreu, D; Albericio, F.; Sole, N. A.; Munson, M. C.; Ferrer, M.; Barany, G. In Peptide Synthesis Protocols; Pennington, M. W.; Dunn, B. M., Eds.; Humana; Totowa; 1994, pp 91-169.
14. 9. Eritja, R.; Ziehler-Martin, J. P.; Walker, P. A.; Lee, T. D.; Legesse, K.; Albericio, F.; Kaplan, B. E. Tetrahedron 1987, 43, 2675.
15. 10. Zuckermann, R. N.; Kerr, J. M.; Kent, S. B. H.; Moos, W. H. J. Am. Chem. Soc. 1992, 114, 10646.